These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 20807704

  • 21. The macrophage scavenger receptor CD163.
    Fabriek BO, Dijkstra CD, van den Berg TK.
    Immunobiology; 2005; 210(2-4):153-60. PubMed ID: 16164022
    [Abstract] [Full Text] [Related]

  • 22. Suppressive effects of polyozellin on endothelial protein C receptor shedding via inhibiting TACE activity and MAP kinases.
    Lee W, Yang EJ, Park DH, Bae JS.
    Fitoterapia; 2016 Jan; 108():26-32. PubMed ID: 26586620
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. A previously unrecognized protein-protein interaction between TWEAK and CD163: potential biological implications.
    Bover LC, Cardó-Vila M, Kuniyasu A, Sun J, Rangel R, Takeya M, Aggarwal BB, Arap W, Pasqualini R.
    J Immunol; 2007 Jun 15; 178(12):8183-94. PubMed ID: 17548657
    [Abstract] [Full Text] [Related]

  • 25. The transmembrane domain of TACE regulates protein ectodomain shedding.
    Li X, Pérez L, Pan Z, Fan H.
    Cell Res; 2007 Dec 15; 17(12):985-98. PubMed ID: 18040288
    [Abstract] [Full Text] [Related]

  • 26. Proteasome inhibition activates the transport and the ectodomain shedding of TNF-alpha receptors in human endothelial cells.
    Peiretti F, Canault M, Bernot D, Bonardo B, Deprez-Beauclair P, Juhan-Vague I, Nalbone G.
    J Cell Sci; 2005 Mar 01; 118(Pt 5):1061-70. PubMed ID: 15731011
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Tumor necrosis factor-alpha-converting enzyme controls surface expression of c-Kit and survival of embryonic stem cell-derived mast cells.
    Cruz AC, Frank BT, Edwards ST, Dazin PF, Peschon JJ, Fang KC.
    J Biol Chem; 2004 Feb 13; 279(7):5612-20. PubMed ID: 14625290
    [Abstract] [Full Text] [Related]

  • 31. Ectodomain shedding of TNF-alpha is enhanced by nardilysin via activation of ADAM proteases.
    Hiraoka Y, Yoshida K, Ohno M, Matsuoka T, Kita T, Nishi E.
    Biochem Biophys Res Commun; 2008 May 23; 370(1):154-8. PubMed ID: 18355445
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Hemoglobin scavenger receptor CD163 mediates interleukin-10 release and heme oxygenase-1 synthesis: antiinflammatory monocyte-macrophage responses in vitro, in resolving skin blisters in vivo, and after cardiopulmonary bypass surgery.
    Philippidis P, Mason JC, Evans BJ, Nadra I, Taylor KM, Haskard DO, Landis RC.
    Circ Res; 2004 Jan 09; 94(1):119-26. PubMed ID: 14656926
    [Abstract] [Full Text] [Related]

  • 34. The CD163-expressing macrophages recognize and internalize TWEAK: potential consequences in atherosclerosis.
    Moreno JA, Muñoz-García B, Martín-Ventura JL, Madrigal-Matute J, Orbe J, Páramo JA, Ortega L, Egido J, Blanco-Colio LM.
    Atherosclerosis; 2009 Nov 09; 207(1):103-10. PubMed ID: 19473660
    [Abstract] [Full Text] [Related]

  • 35. Constitutive endocytosis of CD163 mediates hemoglobin-heme uptake and determines the noninflammatory and protective transcriptional response of macrophages to hemoglobin.
    Schaer CA, Schoedon G, Imhof A, Kurrer MO, Schaer DJ.
    Circ Res; 2006 Oct 27; 99(9):943-50. PubMed ID: 17008602
    [Abstract] [Full Text] [Related]

  • 36. CD163-L1 is an endocytic macrophage protein strongly regulated by mediators in the inflammatory response.
    Moeller JB, Nielsen MJ, Reichhardt MP, Schlosser A, Sorensen GL, Nielsen O, Tornøe I, Grønlund J, Nielsen ME, Jørgensen JS, Jensen ON, Mollenhauer J, Moestrup SK, Holmskov U.
    J Immunol; 2012 Mar 01; 188(5):2399-409. PubMed ID: 22279103
    [Abstract] [Full Text] [Related]

  • 37. Zidovudine-Based Treatments Inhibit the Glycosylation of ADAM17 and Reduce CD163 Shedding From Monocytes.
    Chen S, Wang X, Zhu H, Tang Q, Du W, Cao H, Lai C, Guo W, Fu L, Lu W.
    J Acquir Immune Defic Syndr; 2018 Sep 01; 79(1):126-134. PubMed ID: 29794822
    [Abstract] [Full Text] [Related]

  • 38. Tumour necrosis factor alpha-converting enzyme mediates ectodomain shedding of Vps10p-domain receptor family members.
    Hermey G, Sjøgaard SS, Petersen CM, Nykjaer A, Gliemann J.
    Biochem J; 2006 Apr 15; 395(2):285-93. PubMed ID: 16393139
    [Abstract] [Full Text] [Related]

  • 39. ADAMs and protein disulfide isomerase: the key to regulated cell-surface protein ectodomain shedding?
    Bass R, Edwards DR.
    Biochem J; 2010 May 27; 428(3):e3-5. PubMed ID: 20504280
    [Abstract] [Full Text] [Related]

  • 40. Proteolytic shedding of the macrophage scavenger receptor CD163 in multiple sclerosis.
    Fabriek BO, Møller HJ, Vloet RP, van Winsen LM, Hanemaaijer R, Teunissen CE, Uitdehaag BM, van den Berg TK, Dijkstra CD.
    J Neuroimmunol; 2007 Jul 27; 187(1-2):179-86. PubMed ID: 17537523
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.